ImmunityBio, Inc.'s Anktiva shows promise for solid tumors, with growing sales and financing boosting growth potential. Click ...

ImmunityBio IBRX shares rallied 27.2% on Thursday after it announced that it has completed the regulatory filing process in ...

Stock futures edged higher on Friday, following an eventful week marked by strong bank earnings and a slew of mixed economic data. Here are some of Friday's biggest stock movers: Biggest stock gainers ...